Linked Data API

Show Search Form

Search Results

1149807
star this property registered interest false more like this
star this property date less than 2019-10-15more like thismore than 2019-10-15
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Alcoholic Drinks: Misuse more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the impact of alcohol on health, and health inequalities; and what plans they have to prevent alcohol harm. more like this
star this property tabling member printed
Baroness Hayter of Kentish Town more like this
star this property uin HL99 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-29more like thismore than 2019-10-29
star this property answer text <p>The Government is committed to tackling health harms from alcohol and to support the most vulnerable at risk from alcohol misuse. The Prevention Green Paper <em>Advancing our health: prevention in the 2020s</em> outlines how we will help people moderate their drinking by working with industry to deliver a significant increase in the availability of alcohol-free and low-alcohol products by 2025. The Government will engage with industry and other stakeholders around delivering this objective.</p><p>Lower socioeconomic status is associated with higher mortality for alcohol-attributable causes, despite lower socioeconomic groups often reporting lower levels of consumption. As part of the NHS Long Term Plan, we are establishing specialist Alcohol Care Teams in hospitals with the highest rates of alcohol harm. It is estimated that this will prevent 50,000 admissions over five years. Local authorities will also receive over £3 billion in 2019/20 to be used exclusively on public health including alcohol treatment services. Public Health England is supporting NHS England’s tobacco and alcohol commissioning for quality and innovation scheme, which encourages hospitals to screen all inpatients about their alcohol use and offer appropriate interventions.</p><p>The UK Chief Medical Officers issued Low Risk Drinking Guidelines in 2016 so that people could make informed choices about their own drinking and the Government has worked with industry to ensure information on the health harms of alcohol are printed clearly on the labelling of alcoholic drinks.</p><p>The Government has also made funding of £6 million available to support children who live with an alcohol dependent parent which will address the inequalities facing this vulnerable group.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL101 more like this
HL98 more like this
star this property question first answered
less than 2019-10-29T15:50:45.83Zmore like thismore than 2019-10-29T15:50:45.83Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4159
unstar this property label Biography information for Baroness Hayter of Kentish Town more like this
1149806
star this property registered interest false more like this
star this property date less than 2019-10-15more like thismore than 2019-10-15
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Alcoholic Drinks: Misuse more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the publication of the Prevention green paper in July, what steps they plan to take to address and prevent alcohol harm. more like this
star this property tabling member printed
Baroness Hayter of Kentish Town more like this
star this property uin HL98 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-29more like thismore than 2019-10-29
star this property answer text <p>The Government is committed to tackling health harms from alcohol and to support the most vulnerable at risk from alcohol misuse. The Prevention Green Paper <em>Advancing our health: prevention in the 2020s</em> outlines how we will help people moderate their drinking by working with industry to deliver a significant increase in the availability of alcohol-free and low-alcohol products by 2025. The Government will engage with industry and other stakeholders around delivering this objective.</p><p>Lower socioeconomic status is associated with higher mortality for alcohol-attributable causes, despite lower socioeconomic groups often reporting lower levels of consumption. As part of the NHS Long Term Plan, we are establishing specialist Alcohol Care Teams in hospitals with the highest rates of alcohol harm. It is estimated that this will prevent 50,000 admissions over five years. Local authorities will also receive over £3 billion in 2019/20 to be used exclusively on public health including alcohol treatment services. Public Health England is supporting NHS England’s tobacco and alcohol commissioning for quality and innovation scheme, which encourages hospitals to screen all inpatients about their alcohol use and offer appropriate interventions.</p><p>The UK Chief Medical Officers issued Low Risk Drinking Guidelines in 2016 so that people could make informed choices about their own drinking and the Government has worked with industry to ensure information on the health harms of alcohol are printed clearly on the labelling of alcoholic drinks.</p><p>The Government has also made funding of £6 million available to support children who live with an alcohol dependent parent which will address the inequalities facing this vulnerable group.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL101 more like this
HL99 more like this
star this property question first answered
less than 2019-10-29T15:50:45.717Zmore like thismore than 2019-10-29T15:50:45.717Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4159
unstar this property label Biography information for Baroness Hayter of Kentish Town more like this
1149777
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Transplant Surgery more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether liver and bowel transplantation is currently approved by the National Institute for Health and Care Excellence for cancer patients; and if not, whether there are any clinical trials that have reached Phase 3. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL70 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>The National Institute for Health and Care Excellence has not produced any guidance relating to combined liver and bowel transplants for cancer patients.</p><p>The Department funds research mainly through the National Institute for Health Research (NIHR). The usual practice of the NIHR and other research funders is not to ring-fence funds for expenditure on particular topics. The NIHR welcomes funding applications for research into any aspect of human health, including liver and bowel transplantation.</p><p>There has been one relevant clinical trial that reached Phase 3:</p><p>Study title: In open, prospective, single arm study investigating efficacy and safety of human hepatitis B immunoglobulin Zutectra in liver transplanted patients - the ZEUS Study.</p><p>Date: 22 November 2012 – 10 April 2014</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-25T11:56:33.353Zmore like thismore than 2019-10-25T11:56:33.353Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1149714
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Mental Capacity: Codes of Practice more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government when consultation on the Code of Practice issued under the Mental Capacity (Amendment) Act 2019 will commence. more like this
star this property tabling member printed
Baroness Barker more like this
star this property uin HL7 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>Following Royal Assent for the Mental Capacity (Amendment) Act 2019, the Department has been engaging across England and Wales with a range of key stakeholders from the health and social care sector and people with lived experience to co-produce the Code of Practice for the new Liberty Protection Safeguards. We plan to start public consultation in the new year and the Code will be laid before both Houses ahead of the new Liberty Protection Safeguards system coming into force.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-25T11:55:05.753Zmore like thismore than 2019-10-25T11:55:05.753Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
2501
unstar this property label Biography information for Baroness Barker more like this
1149776
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Bevacizumab more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, if Avastin is approved for safe use, whether it could be privately purchased for use by a patient being treated on the NHS. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL69 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-28more like thismore than 2019-10-28
star this property answer text <p>For patients receiving private and National Health Service care for the same condition, NHS and private treatment can be supervised by one healthcare team. However, patients cannot choose to mix different parts of the same treatment between NHS and private care.</p><p>For example, a patient cannot have a cataract operation on the NHS and pay privately for special lens implants that are normally only available as part of private care.</p><p>Instead, a patient either has both the operation on the NHS and standard NHS lens implants or pay for both the operation and implants privately.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-28T12:58:25.74Zmore like thismore than 2019-10-28T12:58:25.74Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1149775
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Bevacizumab more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether there are (1) current applications, or (2) pending requests, for the use of Avastin following Phase 3 clinical trials. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL68 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>To extend the indication of Avastin, the Marketing Authorisation Holder (Roche Registration GmbH) would need to submit the results of relevant clinical trials and other information to the European Medicines Agency (EMA) to demonstrate acceptable safety and efficacy and a positive balance of benefit to risk. At present, as Avastin has a European Community Marketing Authorisation, a national submission to the Medicines and Healthcare products Regulatory Agency to extend the indication is not possible.</p><p>There has not been any recent positive opinion from the EMA for a new indication of Avastin to be submitted to the European Commission and the EMA has not published any pending extension of indication applications.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-25T12:11:29.293Zmore like thismore than 2019-10-25T12:11:29.293Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1149774
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Bevacizumab more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether Avastin has approval from the European Medicines Authority to be used to treat cancer. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL67 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>Avastin has approval from the European Medicines Agency to be used to treat cancer in combination with specific chemotherapies in the advanced stages of several cancers. They are:</p><p>- Metastatic colorectal cancer;</p><p>- Metastatic breast cancer;</p><p>- Certain types of unresectable advanced, metastatic or recurrent lung cancer;</p><p>- Advanced or metastatic renal cell cancer;</p><p>- Advanced or recurrent or resistant ovarian/fallopian tube cancer; and</p><p>- Persistent or recurrent or metastatic cervical cancer.</p><p>Full details of the indications that Avastin is licensed for can be found in the European public assessment report for Avastin. It explains how the Agency assessed the medicine to recommend its authorisation and its conditions of use and is publicly available on their website.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-25T12:00:04.5Zmore like thismore than 2019-10-25T12:00:04.5Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1149773
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Bevacizumab more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government why Avastin is not routinely made available on the NHS for certain groups of cancer patients. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL66 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>Most new medicines are assessed by the National Institute for Health and Care Excellence (NICE) which makes recommendations for the National Health Service on whether they represent a clinically and cost effective use of NHS resources. Since 2016, NICE makes recommendations for the NHS on all new licensed cancer medicines through its technology appraisal programme. NHS commissioners are legally required to fund treatments recommended in NICE technology appraisal guidance.</p><p>NICE has appraised Avastin (bevacizumab) for use in the treatment of a number of different types of cancer and has unfortunately not been able to recommend it as a clinically and cost effective use of NHS resources for any type of cancer at the price offered by the drug company. Avastin is not therefore routinely funded by the NHS for any licensed indication.</p><p>Avastin is funded as an off-label treatment for some types of cancer through the Cancer Drugs Fund.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-10-25T11:56:13.193Zmore like thismore than 2019-10-25T11:56:13.193Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1149713
star this property registered interest false more like this
star this property date less than 2019-10-14more like thismore than 2019-10-14
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Fertility: Medical Treatments more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales &amp; Ors [2019] EWHC 2384 (Fam) on members of the trans community who wish to access fertility treatment at a licensed clinic. more like this
star this property tabling member printed
Baroness Barker more like this
star this property uin HL6 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>The Court found that the scheme of birth registration for the children of trans men is lawful and proportionate. The Government welcomes the Court’s decision.</p><p>The Government’s view is that the judgment has no effect on the availability of regulated fertility treatment and will now consider whether there should be further guidance to clarify this position. The Government considers that regulated fertility treatment is currently, and will remain, equally available to all (trans) women and (trans) men under the Human Fertilisation and Embryology Acts.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL5 more like this
star this property question first answered
less than 2019-10-25T11:54:37.657Zmore like thismore than 2019-10-25T11:54:37.657Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
2501
unstar this property label Biography information for Baroness Barker more like this
1167888
star this property registered interest false more like this
star this property date less than 2019-11-04more like thismore than 2019-11-04
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rehabilitation: Conferences more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government which representatives attended the World Health Organisation Second Global Rehabilitation 2030 meeting in Geneva on 8 and 9 July. more like this
star this property tabling member printed
Lord Wigley more like this
star this property uin HL589 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-11-05more like thismore than 2019-11-05
star this property answer text <p>There were no United Kingdom Government representatives on the final list of participants for the Second Global Rehabilitation 2030 Meeting in Geneva on 8 and 9 July 2019. A number of medical, academic and other representatives from the UK did however take part. The list of participants is attached due to the size of the data.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-11-05T17:02:44.32Zmore like thismore than 2019-11-05T17:02:44.32Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
547
unstar this property label Biography information for Lord Wigley more like this